PMN
|
Biden would know, or used to before his dementia, either way really.
|
PMN
|
Will Gene bet our brand marketing on another lame horse? https://endpts.com...
|
PMN
|
FarmerBetty wrote: No disdain just stating facts, they have been doing mouse...
|
PMN
|
bball67 wrote: . The Company believes that these results were significant...
|
PMN
|
And given the incredible scrutiny aducanumab's numbers eventually faced...
|
PMN
|
Exactly, so what were the numbers? Maze readouts are usually time meaurements...
|
PMN
|
"showed a significant cognitive benefit in a widely recognized animal...
|
PMN
|
By itself, nothing. Abbvie seems to like keeping a toe in the water, nothing...
|
PMN
|
Is this the start of some sector pipeline construction? https://endpts.com...
|
PMN
|
to be a fly on the wall...
|
PMN
|
Speyeder999 wrote: WOW!... I'd like to see Cashman et al mention...
|
PMN
|
lot's to like there, thanks I wasn't betting on Tramisprosate but...
|
PMN
|
Not a chance. Goldstein took heat here for unwarranted PR but PMN has...
|
PMN
|
Gbathat wrote: Probably because the bigger companies are not offering what...
|
PMN
|
Let's not confuse insight with opinion. Your question got me to browse...
|
PMN
|
azzymaa wrote: why doesn't pmn just get bought out by a bigger company if...
|
PMN
|
Why does Promis promote the idea that 310 is in the same class as aducanumab?...
|
PMN
|
He does make a lot of sense, so does MSM. I get blank stares like yours from...
|
PMN
|
Ok, here's your blindspot RC: Promis shareholders are asked to believe...
|
PMN
|
Nebulous statements like that have always been in the presentations, but...
|